Skip to main content
. 2014 Sep 5;19(9):13990–14003. doi: 10.3390/molecules190913990

Figure 5.

Figure 5

Pretreatment with MβCD suppresses the inhibitory effect of AKL on SLO-induced hemolysis. White columns: hemagglutination activity of AKL in RBCs pretreated with (+) or without (−) 12.5 mM of MβCD. Shaded columns: inhibitory effect of pretreatment with 12.5 mM of MβCD on hemolytic activity of 2 mg/mL AKL in RBCs in the presence of SLO. Error bars: SE from three independent cell preparations assayed individually. * p < 0.01 in comparison with negative control.